Bill Blair

Polarean, Inc. designs and manufactures equipment for production of hyperpolarized xenon or helium gas. It sells hyperpolarizes and related equipment to academic research institutions. The company was founded by Bastiaan Driehuys and John Sudol in January 2012 and is headquartered in Durham, NC.

Mobeus Equity Partners LLP (Mobeus Equity Partners) is an independent private equity firm founded in 2012. The firm is headquartered in London, the United Kingdom.

nView medical, Inc. develops and manufactures medical imagining equipment. The company was founded by Cristian Atria and is headquartered in Salt Lake City ,UT.

BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands.

Ossianix, Inc. develops single domain antibodies. It develops biotherapeutic products using the versatile single domain VNAR antibody from the shark and also developed highly innovative approaches to target specific cells and tissues such as the brain via the blood brain barrier and peripheral nerve via the neuromuscular junction. The company was founded by Frank S. Walshin, J. Lynn Rutkowski and Corey S. Goodman in 2011 and is headquartered in Philadelphia, PA.

NinePoint Medical, Inc. develops and manufactures medical devices. It designs, manufactures, and sells an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology, pulmonology, urology, gynecology, evaluation of human tissue microstructure. The company is headquartered in Bedford, MA.

Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.

NeuroTherm, Inc. develops and manufactures products for the treatment of chronic pain. The company offers radiofrequency (RF) generators, RF electrodes, RF cannula, intradiscal therapies, discography systems, and epidural catheters. The company was founded in 2005 and is headquartered in Abbott Park, IL.

Integra, Inc. Provides employee assistance programs & managed behavioral healthcare services through full and shared risk arrangements with managed care organizations, health plans and employers typically on a capitated per member (employee) per month basis. The Company provides an array of other behavioral health services including: third party clinical case management and claims administration. The company was founded in 1999 and is headquartered King of Prussia, PA.

Founded in 2019, Bracco Horizons Ltd. is a British biotechnology company that engages in research and development of biotechnology products. Part of Bracco SpA, the company is based in Oxford, UK.

Blue Earth Diagnostics Ltd. engages in the development and commercialization of positron emission tomography imaging agents. It focuses on the molecular imaging diagnostics. The company was founded in March 2014 and is headquartered in Oxford, the United Kingdom.

Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark.

ReNeuron Ltd. researches and develops drugs, diagnostics, and other therapeutic products. The company was founded on May 23, 1997 and is headquartered in Bridgend, the United Kingdom.

Part of WebMD Health Corp., VetInsite.com, Inc. provides strategic communications between veterinary hospitals and their clients. The company is based in Silver Spring, MD. VetInsite.com was acquired by MediMedia USA, Inc. on December 03, 2007.

Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021.

Part of Tectonic Therapeutic, Inc., Tectonic Operating Co., Inc. is a company that is transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company is based in Watertown, MA. With its proprietary Geode™ platform, Tectonic aims to unlock the therapeutic utility of some of the most difficult receptors in the class. The company was founded by Andrew Kruse and Timothy A. Springer. Alise S. Reicin has been the CEO of the company since 2020. Tectonic Operating Co. was acquired by AVROBIO, Inc. on June 20, 2024 for $7.56 million.

The North East Fund Ltd. provides unsecured funding for small and medium-sized enterprises (SMEs) based in Tyne & Wear and County Durham, which can service debt but cannot obtain sufficient bank lending to implement growth plans. The private company is based in Forth Banks, UK. The British company also offers equity investment for growth through the North East Venture Fund, which is available to companies in most sectors. The CEO of the company is Jason Lee Hobbs.

Embrex LLC manufactures agricultural and biological products. The company was founded by Harold V. Smith in 1985 and is headquartered in Parsippany, NJ.

Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom.